Current models of B lymphocyte biology posit that B cells continuously recirculate between lymphoid organs without accumulating in peripheral healthy tissues. Nevertheless, B lymphocytes are one of the most prevalent leukocyte populations in the naive murine heart. To investigate this apparent inconsistency in the literature, we conducted a systematic analysis of myocardial B cell ontogeny, trafficking dynamics, histology, and gene expression patterns. We found that myocardial B cells represent a subpopulation of circulating B cells that make close contact with the microvascular endothelium of the heart and arrest their transit as they pass through the heart. The vast majority (> 95%) of myocardial B cells remain intravascular, whereas few (< 5%) myocardial B cells cross the endothelium into myocardial tissue. Analyses of mice with B cell deficiency or depletion indicated that B cells modulate the myocardial leukocyte pool composition. Analysis of B cell deficient animals suggested that B cells modulate myocardial growth and contractility. These results transform our current understanding of B cell recirculation in the naive state and reveal a previously unknown relationship between B cells and myocardial physiology. Further work will be needed to assess the relevance of these findings to other organs.
Introduction
B lymphocytes are one of the most prevalent leukocytes in the naive murine heart (1) (2) (3) . Prior studies have shown that modulating the number and function of myocardial B cells confers cardioprotective effects in both acute and chronic myocardial injury (2, (4) (5) (6) . However, the basic biology of myocardial B cells in the naïve heart is unknown. Indeed, myocardial B cell ontogeny, trafficking dynamics, histology, and identity have not been investigated in the naïve heart.
Currently, it is not clear why there is a large B cell population in the naive myocardium.
According to current models of B cell trafficking, B cells recirculate between primary and secondary lymphoid organs until binding their cognate antigen (7) (8) (9) . This model does not predict that B cells should accumulate in non-lymphoid healthy tissue. Given that B cells play an important role in myocardial injury (2, (4) (5) (6) , it is crucial to elucidate the biology of myocardial B cells in the naive state to assess the potential of B cell targeting therapies for cardiac diseases.
Here, we investigated the ontogeny, trafficking dynamics, histology, and gene expression profiles of myocardial B cells in order to resolve the apparent inconsistencies between current models of B cell recirculation and the observed populations of B lymphocytes in the naive heart (2) (3) (4) (5) 10) .
Results

Murine myocardium contains bone marrow-derived and non-bone marrow derived B cells
The murine naive heart harbors a relatively large population of B lymphocytes (2, 4, 10, 11) .
However, it is not clear whether myocardial B cells are embryonic (non-bone marrow) derived or derived from the bone marrow. Since embryonic derived B lymphocytes accumulate in specific niches within tissues (12) , we hypothesized that myocardial B cells would be predominately comprised of non-bone marrow derived cells. To test this hypothesis, we transplanted bone marrow from CD45.1 mice into lethally irradiated CD45.2 B cell deficient animals (MT) (13) .
Myocardial B cells can be grouped into three sub-populations: CD19 + CD11bˉ, CD19 + CD11b + IgM + CD5 + , and CD19 + CD11b + IgM + CD5ˉ (2) . Bone marrow transplant reconstituted two of three B cell populations in the heart ( Fig. 1 A-B ). Hearts from bone marrow transplant recipients harbored CD19 + CD11bˉ and CD19 + CD11b + IgM + CD5 -B cell populations but lacked CD19 + CD11b + IgM + CD5 + cells, suggesting that the latter population is not derived from bone marrow progenitors, thus disproving our initial hypothesis. To confirm these results and to eliminate potential confounding effects associated with radiation-induced damage to the heart, we repeated the experiment by performing limited bone marrow ablation through focused irradiation of the femurs. This altered irradiation strategy did not qualitatively alter the results and confirmed that most myocardial B cells are bone marrow derived ( Supplementary Figure 1 A-B).
Myocardial B cells recirculate between the heart, blood, and spleen
The investigation of the origin of myocardial B cells described above did not explain the existence of a large pool of myocardial B cells. Therefore, we formulated a different hypothesis.
Since several populations of resident lymphocytes have been described (14) , and the heart harbors resident leukocyte populations (15) we hypothesized that myocardial B cells might represent a population of tissue resident B lymphocytes. To test this hypothesis, we conjoined CD45.1 and CD45.2 mice via parabiosis and analyzed myocardial B cell chimerism 3 weeks after surgery. The results indicated that both CD19 + CD11b + and CD19 + CD11bˉ cells displayed approximately 50% chimerism after 3 weeks of parabiosis ( Figure 1C ), suggesting that the vast majority of myocardial B cells have immediate access to the circulation and freely recirculate between conjoined animals. To confirm this result and investigate the trafficking dynamics of myocardial B cells, we performed heterotopic heart transplant. We transplanted the heart of a CD45.2 mouse into the abdomen of a CD45.1 mouse, so that both hearts were connected to the vasculature and perfused at the same time. Untransplanted hearts from CD45.1 and CD45. whereas the vast majority of cells transplanted with the donor heart were not observed in the myocardial tissue of the recipient mouse. This result confirmed that the vast majority of myocardial B cells are not tissue resident cells, and also suggested that myocardial B cells can migrate from the heart to other organs.
To identify where myocardial B cells traffic after leaving the heart, we analyzed the spleen and blood of mice that received the heart transplant. The results showed that similarly to the myocardium, the spleen and blood of recipient mice also contained a small but clearly detected fraction of B cells derived from the donor heart (Figure 2A ), suggesting that myocardial B cells recirculate between the heart, blood, and spleen. We confirmed this result by performing adoptive transfer of splenocytes into Rag1 -/mice, which are deficient in B cells and lack myocardial B cells ( Figure 2B ). Four weeks after adoptive transfer of splenocytes from a wildtype mouse, Rag1 -/mice had detectable myocardial B cells. The wild-type spleen is known to harbor both bone marrow derived and non-bone marrow derived B cells and accordingly adoptive transfer of wild-type splenocytes reconstituted all three sub-populations of myocardial B cells (Figure. 2B).
Myocardial B cells are primarily intravascular and closely contact the endothelium
Our data failed to explain why a relatively large population of B cells is observed in perfused naive hearts. Therefore, we investigated the histological location of myocardial B cells, specifically examining whether they were intravascular or intraparenchymal, by generating a CD19-tdTomato reporter mouse that efficiently labeled B cells ( Fig. S1D -E). The results showed that myocardial B cells were sparsely distributed throughout the myocardium ( Figure 3A ). When we stained for CD31 sections from CD19-tomato reporter animals to identify the vasculature and localize B cells in relationship to the endothelium, we found that most myocardial B cells were intravascular. Most B cells were in the microvasculature and were in close proximity to surrounding endothelial cells ( Figure 3B ). Some B cells were found in clusters of 2 or 3 cells ( Figure 3C ). Few B cells were observed in the intraparenchymal/extravascular space; these were isolated cells or small clusters of 2-3 cells ( Figure 3D , Supplementary Figure 1E and Video S1). Rare B cells were found to be in transit through the endothelium ( Figure 3E and Video S2). To confirm the intravascular localization of myocardial B cells, we performed intravascular injection of a CD45.2 antibody immediately before sacrificing the mice and collecting the hearts for flow cytometric analysis. Under these conditions, only cells located in the intravascular space are stained by the injected antibody (16) . Consistent with our histological analysis, essentially all myocardial B cells were stained by the CD45.2 antibody ( Figure 3F ). Only 3% of myocardial B cells were not stained by the CD45.2 antibody, indicating that they were not in the intravascular space at the time of analysis ( Figure 3F , bar graph).
Myocardial B cells transcriptional profile differs from that of circulating B cells
Our results did not exclude the possibility that myocardial B cells might simply represent circulating B cells that were left in the myocardial vasculature at the time of organ harvesting. To address this question, we first compared our standard organ perfusion protocol with large volume retrograde perfusion after aortic cannulation and confirmed that even the most stringent perfusion protocol did not eliminate myocardial B cells. (Supplementary figure S2 ). Then we performed single-cell sequencing of FACS-sorted myocardial B cells and B cells sorted from circulating blood using the Chromium kit and instrument from 10x Genomics (Accession number GSE142515). The myocardial and circulating B cell samples were collected from the same mice and at the same time. The results showed that the myocardial B cell transcriptional profile distinctly differed from that of circulating B cells ( Figure 4A ). We identified the top five genes with the highest differential expression levels and frequencies between myocardial and circulating B cells (Supplementary table 1). Among these five genes, we identified two that had either available antibodies for flow cytometry (CD83) or an available reporter strain (Nr4a1).
Flow cytometry analysis showed that myocardial B cells had higher CD83 and NR4a1 expression levels than circulating B cells (Figs. S2A-B), which confirmed the gene expression analyses. Next, we performed gene set enrichment analysis (17) of the differentially expressed genes in heart and blood B cells. Table 1shows that myocardial B cells displayed activation of the MAPK signaling pathway, B cell receptor signaling pathway, antigen processing and presentation, chemokine signaling pathway, and leukocyte transendothelial migration.
Myocardial B cells are a subset of circulating B lymphocytes that accumulate in the myocardium
We performed unsupervised clustering of the single-cell transcription data. Virtually all identified clusters were represented in both circulating and myocardial B cells, which is consistent with the point of view that myocardial B cells recirculate through the blood. However, analyses of the contributions of myocardial and circulating B cells to each cluster indicated that their prevalence differed according to the cluster. Cluster 0 almost exclusively contained myocardial B cells, whereas clusters 1, 2, and 3 almost exclusively contained circulating B cells ( Figure 4B ). These results suggest that myocardial B cells represent a subset of circulating B lymphocytes that make close contact with the microvascular endothelium in the heart and then arrest their transit.
We tested this hypothesis by performing an ex vivo perfusion experiment. We reasoned that if a subset of circulating B cells adheres to the myocardial vasculature then perfusing the heart of a mouse deficient in B cells with wild-type blood would replenish myocardial B cells. We modified a Langendorff perfusion system to perfuse hearts collected from MT/CD45.2 B cell-deficient mice with peripheral blood collected from wild-type CD45.1 mice (Video S3). As predicted, perfusion of B cell-deficient hearts with wild-type blood resulted in re-population of myocardial B cells similar to that observed in wild-type hearts ( Figure 4C ). Next, we confirmed this result by transplanting a wild-type heart into a syngeneic CD19-TdTomato reporter mouse and performed intravital microscopy. The results showed that although many circulating B cells rapidly transit through the myocardial vasculature, a significant number of these cells either pause during their transit through the heart or markedly slow down during transit. We observed some B cells moving along the vascular wall with a motion similar to the patrolling movement classically described for monocytes ( Figure 4D and Video S4) (18) .
Myocardial B cells are primarily naive follicular B cells
To further identify specific subtypes of myocardial B cells, we analyzed the single-cell gene expression data. Myocardial B cells expressed Stat4, Nkbb2, Rel-a, Rel-b, Klf-3, and Klf-6, but did not express Blmp1, Tox, Pbx3, Klf-9, or Ahr (Supplementary figure2C). This gene expression profile is consistent with that of naive B cells (19, 20) . Nr4a1 was the most strongly upregulated gene in the differential gene expression analysis ( Supplementary Table 1 ), and has been implicated in downstream signaling of the B cell receptor (BCR) (21) . To address whether activation of BCR signaling was responsible for B cell adherence to the endothelium, we compared the number of myocardial B cells between genetically modified mice that uniformly express a BCR with specificity for a non-murine antigen (HEL mice) and syngeneic, age/sexmatched wild-type control mice. The results showed that HEL mice did not have markedly fewer myocardial B cells than control mice, suggesting that BCR specificity is not a major driver of B cell accumulation in the heart (Supplementary Figure S4A) .
B cell deficiency alters the myocardial leukocyte pool, reduces myocardial mass, and alters left ventricular contractility
Next, we investigated the functional significance of B lymphocytes in the naive heart by comparatively analyzing the myocardium of wild-type mice and syngeneic, age/sex-matched MT B cell-deficient mice. We first analyzed the myocardial leukocyte pool using flow cytometry (Supplementary Figure S4B describes the gating strategy). The results showed that B celldeficient mice had fewer myocardial Ly6C + monocytes and more CD4 + and CD8 + myocardial T cells ( Figure 5A ). We also investigated the role of induced versus genetic B cell depletion with respect to modulating the myocardial leukocyte pool. Wild-type mice were administered anti CD20 antibody (2) to deplete their B cells, and then they were compared with isotype controltreated mice. Antibody-mediated B cell depletion numerically increased Ly6G + neutrophils and significantly increased myocardial CD4 + and CD8 + T cells ( Figure 5B ). Although the effect of chronic genetic B cell depletion on the myocardial leucocyte pool differed from that of acute antibody-mediated B cell depletion, the results of both experiments support the hypothesis that B cells modulate the leukocyte pool in the naïve heart.
We examined myocardial structure and left ventricular systolic function in MT B celldeficient mice and matched syngeneic wild-type controls. We analyzed myocardial structure by assessing cardiomyocyte and myocardial size via wheat germ agglutinin (WGA) staining and gravimetric analysis, respectively. The MT B cell-deficient mice had smaller myocardial fiber cross-sectional area and lower myocardial mass than age-matched syngeneic controls ( Figure 5 C-D). Left ventricular function was assessed via echocardiography. The MT B cell-deficient mice had higher left ventricular ejection fraction, faster left ventricular relaxation than matched syngeneic controls ( Figure 5E , Supplementary Table 2 and Supplementary figure 5).
Human heart harbors intravascular B cells in close association with the endothelium
We explored the relevance of our results to humans by analyzing fresh specimens of human left ventricle collected at the time of left ventricular assist device implantation. Human heart tissue was enzymatically digested and analyzed via flow cytometry. The results showed that human heart harbored a population of B cells ( Figure 5F ). Next, we stained histological sections of human myocardium with an antibody recognizing the B cell-specific antigen CD20. We observed that human myocardial B cells were almost exclusively intravascular and in close association with the endothelium (Figures 5G), similar to what we observed for murine myocardial B cells.
Discussion
Gowans and Knight performed the classic studies of B lymphocyte recirculation in the1960s (8) .
Since then, immunologists have believed that B lymphocytes continuously recirculate between primary and secondary lymphoid organs without accumulating in peripheral tissues (7) (8) (9) .
However, we and others have observed a relatively large pool of B lymphocytes in the naive heart (1) (2) (3) (4) (5) 10) . The present study investigated this apparent inconsistency and found that a subpopulation of circulating B cells makes close contact with the microvascular endothelium in the heart and arrest their transit as they pass through the heart. These myocardial B cells upregulated specific signaling pathways such as antigen processing and presentation and chemokine-chemokine signaling and patrolled along the endothelium. These results redefine the current paradigm of B lymphocyte recirculation in the naive state. In addition, we observed that B lymphocytes modulated the myocardial leukocyte pool composition, myocardial mass, and left ventricular contractility in B cell-deficient or depleted mice. Our observations revealed an unexpected relationship between circulating B lymphocytes and myocardial biology, thereby challenging the widespread belief that leukocytes function in tissue homeostasis only after extravasating and entering the parenchyma (16) .
We began our investigation of B cells in the naive heart by identifying the origin of the 3 murine myocardial B cell subpopulations: CD19 + CD11bˉ, CD19 + CD11b + IgM + CD5 + , and CD19 + CD11b + IgM + CD5ˉ. We observed that bone marrow transplant effectively repleted the CD19 + CD11bˉ population, repleted the CD19 + CD11b + IgM + CD5ˉ population with low efficiency, and failed to replete the CD19 + CD11b + IgM + CD5 + population (Figure 1 A-B ). Based on the existent literature (22) , our findings suggest that myocardial CD19 + CD11b + IgM + CD5 + cells are embryo-derived B1a cells, whereas CD19 + CD11b + IgM + CD5ˉ and CD19 + CD11bˉ myocardial B cells are respectively B1b and B2 bone marrow derived cells. These observations suggest that the murine myocardium harbors B cells with different ontogenies.
We studied the dynamics of myocardial B cell trafficking using parabiosis and heart transplant. The analysis of parabiotically conjoined mice indicated that both B1 and B2 myocardial B cells undergo recirculation ( Figure 1C ). Analyses of mice subjected to heterotopic heart transplant confirmed this result and suggested that the rate of B cell transit through the heart is relatively fast, as only 0.2% of donor-derived myocardial B cells were observed in the transplanted heart at 4 days after surgery ( Figure 1C ). Analyses of blood, heart, and spleen from the heart transplant recipient mice suggested that myocardial B cells likely migrate widely within murine tissues ( Figure 2 ). Our experimental design did not enable quantification of the number of B cells transplanted with each heart or of the number of B cells recovered in different organs analyzed at the time of harvest. Therefore, we could not determine whether some of the transplanted myocardial B cells died within the transplanted heart or migrated to other recipient organs that were not analyzed.
Given that we consistently observed relatively large pools of myocardial B cells in flow cytometric analysis of digested hearts, we performed a histological analysis of myocardial B cells to define their anatomic location and their relationship with the endothelium. The results showed that B cells were almost exclusively intravascular in naive perfused hearts ( Figure 3 ).
One possibility is that these myocardial B cells may be an artifact of poor perfusion at the time of tissue harvesting. However, extensive perfusion during repeated experiments reduced but did not eliminate the observed myocardial B cell pools (Supplementary figure 2) , and single-cell sequencing indicated that myocardial B cells have distinct gene expression patterns when compared to circulating B cells ( Figure 4A ). Clustering analysis showed that myocardial B cells are highly enriched in specific naive circulating B cell subtypes (Cluster 0 in Figure 4C ). These results should be interpreted with caution because of the small number of events recorded within cluster zero in the sample of circulating B cells. However, since myocardial B cells are predominately intravascular, these combined results suggested that subtypes of circulating B cells with specific properties adhere to the endothelium and have longer permanence time in the myocardium than other subtypes. The observation that some circulating B cells adhere to the endothelium and persist in the myocardium was confirmed by our ex vivo perfusion study ( Figure 4D ) and intravital microscopy imaging ( Figure 4E and Video S4). Although neither of these experiments analyzed completely naive hearts, both experiments exposed naïve hearts to cold ischemia, which was minimized to <10 min for the ex-vivo perfusion experiments and to <30 min for the intravital microscopy experiments. Therefore, we consider that it is reasonable to conclude that the observed results are relevant to naive heart biology.
Circulating B cells are primarily naive follicular B cells (23) , and the gene expression profiles of myocardial B cells across gene expression clusters were consistent with this B cell subtype ( Supplementary Figure 3) . This result suggests that myocardial B cells are primarily a subgroup of naive follicular B cells that transitioned into a specific functional state. Our data suggest that myocardial B cells are naïve circulating B cells that are prone to engaging the endothelium and upregulate patrolling and antigen processing functions in the context of immune surveillance. Further studies will be needed to verify this hypothesis and to understand whether these "slow transiting" B cells that we have observed in the heart are specific to the myocardium or exist also in other organs.
The myocardial leukocyte pool compositions of B cell-deficient and B cell-depleted mice differ from that of control mice ( Figure 5A-B ). The number of CD4 + and CD8 + myocardial T cells was increased in the absence of B cells. This result is corroborated by previous literature suggesting that B cells regulate the trafficking of T cells in the context of tissue injury (24) . B cell deficiency altered also myocardial monocytes, but the results observed were not consistent between antibody-mediated depletion and B cell-deficiency due to a genetic mutation. This difference could be due to the fact that antibody-mediated B cell-depletion causes an acute loss of B cells, whereas MT mice are deprived of B cells throughout life. Another possible explanation is that MT mice lack functional B1 cells, whereas antibody-mediated B cell depletion preserves B1 cells (2) . It should also be noted that we did not measure the concentration of circulating leukocytes in B cell deficient/depleted animals and controls. While the organs studied where all carefully perfused, difference in the circulating leukocyte numbers could have to some extent affected our findings.
We observed that B cell-deficient mice had smaller hearts, smaller myocardial fiber crosssections, and higher left ventricular ejection fraction ( Figure 5C-E) . These observations combined with our other results challenge the belief that leukocytes are not important for tissue homeostasis until they transition into the parenchyma (16) . Myocardial B cells displayed upregulation of chemokine-chemokine signaling pathways and expressed several cytokines such as TGF-beta1 (Supplementary figure 3) , a known myocardial growth factor (25) . Therefore, we propose that the effect of B cell ablation on myocardial mass might be due to an indirect paracrine communication between lymphocytes and cardiomyocytes. However, we studied myocardial mass in a genetic model of global B cell depletion (MT mice) and therefore our experiments do not allow us to differentiate between intracardiac vs extracardiac effects of B cells. SinceMT mice have the same blood pressure as syngeneic controls (25) the observed difference in myocardial mass are unlikely to be due to variations in myocardial afterload, but other potential extracardiac effects of B cell depletion cannot be excluded. Mice have been a powerful model to study immune systems. However, there are many discrepancies between murine and human immunity (26) . Therefore, we also evaluated human heart samples, and observed that the human heart harbors B cells that are primarily intravascular and in close contact with the endothelium (Figure 5F-G) . This result has the important limitation that it was collected from failing hearts and not naïve hearts. However, it was consistent with our observations in the murine studies and suggests that our data might have relevance for human biology. Future studies will be needed to further evaluate these data using human myocardial B cells and heart tissue.
In summary, we demonstrated that the pool of myocardial B cells represents a subset of circulating B cells that adhere to the naïve heart endothelium and arrest their transit as they pass through the heart. We found that the vast majority (> 95%) of myocardial B cells remain intravascular and few (< 5%) myocardial B cells cross the endothelium into myocardial tissue.
We observed that myocardial B cells have distinct gene expression profiles compared to circulating B cells and that are comprised of B cells with different origins. Analyzing models of global B cell loss we found that B cells play a significant role in modulating the myocardial leukocyte pool, as well as LV structure and function. These results unveil a previously unappreciated relationship between B lymphocytes and the heart. In addition, they show that subsets of naive B lymphocytes interact with the tissue vasculature and have an important physiological role even when they are not engaged in an adaptive immune responses. We hypothesize that these observations highlight a previously unappreciated fundamental property of circulating B cells and that the current model of baseline B cell recirculation requires revision.
Further research will be needed to verify the roles of myocardial B cells in antigen presentation and immune surveillance, to dissect the molecular basis of B cell effects on myocardial structure and function, and to establish whether our observations are relevant to B cell biology in other organs.
Methods
Mice
We used 10-12-week-old female mice for all experiments unless otherwise specified. All mice were purchased from Jackson Laboratory. The following strains were used: wild-type C57/B6J strain N. 000664, B6.129S2-Ighm tm1Cgn /J (MT) strain N.002288, B6.SJL-Ptprc a Pepc b /BoyJ (CD45.1) strain N. 002014, and B6.129S7-Rag1tm1Mom/J (Rag1) strain N. 002216. To generate CD19 reporter mice, B6.129P2(C)-Cd19tm1(cre)Cgn/J males (CD19-cre) were bred with B6.Cg-Gt(ROSA)26Sortm14(CAG-TdTomato)Hze/J females (TdTomato-lox), and F1 mice were studied. For antibody-mediated B cell depletion, 3-weeks-old wild-type mice were injected intraperitoneally with 100 µg of anti-CD20 antibody (BioLegend, Clone SA271G2, Catalog# 152104) or isotype control. After 1 week, mice were re-injected retro-orbitally with 200 µg of anti-CD20 antibody or isotype control and thereafter re-injected with the same amount of antibody every 4 weeks for a total of 3 retro-orbital injections.
Parabiosis
Female donor and recipient mice were shaved, and matching skin incisions were made from behind the ear to the tail of each mouse. The subcutaneous fascia was dissected to create a free skin flap. The olecranon and knee joints were anastomosed using mono-nylon 5.0 suture (Ethicon), and skin flaps were anastomosed using a continuous suture. Postoperative anesthesia included 0.1 mg/kg subcutaneous injection of buprenorphine after surgery and 24 hours later. Mice received 3% neomycin for 2 weeks, and were analyzed at 6 weeks after surgery.
Intravital microscopy
Cardiac grafts were harvested from wild-type B6 mice and immediately transplanted into the right neck of B6 Cd19 TdTomato hosts as described previously (27) . Cold ischemic time was < 30 minutes. Intravital imaging of heart grafts was performed using a custom-built 2-photon microscope running ImageWarp version 2.1 software (A&B Software) as described previously (27) . Time-lapse imaging of lymphocyte trafficking in cardiac grafts was performed by averaging 15 video-rate frames (0.5 seconds per slice) captured during the acquisition to match the ventilator rate and minimize movement artifacts. Each plane represents an image measuring 220240 μm in the x and y dimensions. Twenty-one sequential planes were acquired in the z dimension (2.5 μm each) and compiled to generate a Z-stack. Coronary vessels were visualized by intravenous injection of 50 μl of PBS containing 20 μl of 655-nm nontargeted Q-dots.
Heterotopic intra-abdominal heart transplant
Heterotopic heart transplantation into the abdomen was performed as described previously (28) .
Briefly, animals were anesthetized with 100 mg/kg ketamine HCl and 10 mg/kg xylazine HCl.
Donor hearts were harvested en bloc, with a segment of the ascending aorta transected proximal to the innominate artery and a segment of the pulmonary artery transected close to its bifurcation. Then, donor hearts were implanted into the recipient abdominal cavity by end-toside anastomoses of the donor's ascending aorta and pulmonary artery to the recipient's infrarenal aorta and inferior vena cava, respectively. Hearts were maintained on ice during the interval between harvest and implantation. The estimated time of cold ischemia was 1 hour.
The transplanted hearts were examined by daily check of pulsation until recipients were sacrificed.
Modifed Langendorff perfusion
Hearts were isolated from heparinized MT mice, immediately cannulated on ice, and then immediately transferred to a bath with modified Krebs-Henseleit buffer at 37C. Hearts were perfused at a constant pressure of 70 mm Hg with modified Krebs-Henseleit buffer as described previously (29) . After perfusion with 1 ml of buffer, hearts were perfused with 3 ml of a solution of heparinized blood freshly isolated from wild-type mice and Krebs-Henseleit buffer (1:1, v/v).
Bone marrow transplant and splenocyte adoptive transfer
Bone marrow was collected from the femur of donor mice. Recipient mice were lethally irradiated (10 Gy) and intravenously injected with 5 million bone marrow cells collected on the same day as irradiation. Mice were analyzed for chimerism in the peripheral blood 3 weeks after irradiation, and were consistently found to have >95% chimerism. Hearts were collected for analysis 4 weeks after transplantation.
To perform bone marrow transplant sparing the myocardium from irradiation, we used a small animal radiation research platform (SARRP, Xstrahl, Inc.). To irradiate the femurs, mice were placed on the irradiation platform one at a time and fitted with a nose cone for isoflurane anesthesia. Cone beam computed tomography (CBCT) imaging was performed for each mouse to identify and pinpoint the femurs. The reconstructed CBCT images were imported into Muriplan (Xstrahl), which was used to select an isocenter on the femur. Then, the bilateral femurs were irradiated by administrating 10 Gy using anterior-posterior opposed beams. Mice were returned to the housing facility for post-irradiation analyses.
For splenocyte adoptive transfer, the spleen of one 10-week-old CD45.1 wild-type mouse was minced and passed through a 40-m cell strainer. The cell solution was centrifuged and red blood cells were lysed in ACK lysis buffer (Invitrogen) for 15 min on ice. Splenocytes were resuspended in 200 l of sterile PBS and retro-orbitally injected in an age/sex-matched Rag1 mouse. 
Flow cytometry
Gravimetric and histological analyses
Mice were euthanized and hearts were removed and weighed to determine the heart weight-totibia length ratio. Then, hearts were processed, paraffin-embedded, and stained with wheat germ agglutinin (WGA) as described previously (30) . For immunofluorescence analysis, 10 µm a frozen heart section from CD19-TdTomato reporter hearts was stained with anti-CD-31 primary antibody (polyclonal goat IgG, R&D Systems, product # AF3628), followed by staining with a Northern Light 637 (R&D Systems) conjugated secondary antibody. Sections were imaged using a Zeiss 880 Airyscan Fast 2-photon microscope or Olympus FV1000 2-photon microscope at the Washington University Center For Cellular Imaging (WUCCI).
For histological analysis of human heart, tissue collected and archived at the time of implant of a left ventricular device was used. The hematoxylin-eosin stained slides were reviewed, to avoid area with extensive fibrosis. The CD20 stains were performed using Ventana Autostainer per manufacture's protocol (clone L26), with proper controls.
Echocardiographic studies
Ultrasound examination of the cardiovascular system was performed using a Vevo 2100
Ultrasound System (VisualSonics Inc., Toronto, Ontario, Canada) equipped with a 30 MHz linear-array transducer as described previously (31) .
Single-cell transcriptional profiling
We used the Chromium Single Cell 3′ v3 or 5' Library Kit and Chromium instrument (both from 10x Genomics) to perform single-cell transcriptional profiling analyses. Approximately 17,500 CD19 positive cells sorted from the heart or the blood of three mice were pooled together and partitioned into nanoliter droplets to achieve single-cell resolution for a maximum of 10,000 individual cells per sample. The resulting cDNA was tagged with a common 16-nt cell barcode and 10-12-nt unique molecular identifier during the RT reaction. Full-length cDNA from poly Atailed mRNA transcripts was enzymatically fragmented and selected to optimize the cDNA amplicon size (~400 bp) for library construction (10x Genomics). The single-cell library concentration was quantified by qPCR analysis (Kapa Biosystems) to produce appropriate cluster counts for the NovaSeq 6000 platform (Illumina). We generated 2898 bp (3' Sample demultiplexing, barcode processing, and single-cell 5' counting was performed using the Cell Ranger Single-Cell Software Suite (10x Genomics). Cellranger count was used to align samples to the reference genome (mm10), quantify reads, and filter reads with a quality score below 30. The Seurat package in R was used for subsequent analysis (32) . Cells with mitochondrial content greater than 0.05 percent were removed and the cells which are duplets or mutliplets were filtered out. After removing the damaged cells, data was normalized using a scaling factor of 10,000 and log transformed. The highly variable genes were selected using the FindVariableFeatures function with mean greater than 0.0125 or less than 3 and dispersion greater than 0.5. These genes are used in performing the linear dimensionality reduction.
Principal component analysis was performed prior to clustering and the first 10 PC's were used based on the ElbowPlot. Clustering was performed using the FindClusters function which works on K-nearest neighbor (KNN) graph model with the granularity ranging from 0.1-0.9 and selected 0.6 for the downstream clustering. For identifying the biomarkers for each cluster, we have performed differential expression between each cluster to all other clusters identifying negative and positive markers for that cluster. To generate DEGs, normalized cell-by-cell gene expression generated in previous steps was combined with sample data to separate gene expression data into samples. The linear normalized expression data for all cells in a given sample was averaged for each gene, resulting in a gene-by-sample matrix of "mean gene expression". To calculate "fold change" between circulating and myocardial B cells, the ratio of mean gene expressions for the respective sample was determined. To facilitate data interpretation, a pseudo-count of 0.0001 was added to both the numerator and denominator before determining the ratio to limit the effect of "0" values of mean gene expression on driving large fold changes. Thus, if a gene was not expressed in either genotype for a cluster, the fold change would be 1. Using the MAST algorithm of the Seurat computation package in R, the single-cell expression distributions of two genotypes were compared for all cells, generating the "p-value" for differences between the two genotypes.
To address the possible confounding effect of tissue digestion on the comparison between myocardial and circulating B cells, the experiment was repeated after digesting the peripheral blood with the same enzymes used to digest the myocardium. This control experiment confirmed the differential gene expression observed between myocardial and circulating B cells.
Pathway analysis of genes differentially expressed between myocardial and circulating B cells
was performed using the GSEA software. (17) 
Statistical analyses
Data are expressed as mean ± standard deviation. Two-tailed Student's t-test was used for pairwise comparisons between two groups, adjusting for multiple comparisons with the Benjamini-Hochberg procedure when appropriate. The specific statistical test used for each experiment is indicated in the figure legends. All analyses were performed using GraphPad Prism version 8. A p value <0.05 was used to determine statistical significance. . Flow cytometric analysis of WT animals depleted of B cell through administration of anti-CD20 antibody or isotype control. Antibody mediated B cell depletion is associated with an increase in Ly6G + cells (p=0.056), CD4 + and CD8 + cells. C) Analysis of hearts from 27 weeks old C57/B6J mice and syngeneic age/sex matched MT B animals showed that B cell deficient animals have smaller myocardial fibers cross sectional area as assessed by WGA staining. Representative images of WGA staining for each group are shown and cumulative data are reported. D). B cell deficient animals have lower myocardial mass as assessed by heart weight/tibia length (mg/mm). E) Echocardiographic analysis of left ventricular function in WT mice and matched B cell deficient animals. B cell deficient animals have higher left ventricular ejection fraction (LVEF) and faster ventricular relaxation (dV/dT-d = volume change per unit of time during diastolic relaxation; ESV = end diastolic volume). F) Flow cytometry analysis of a sample of human myocardium collected at the time of implantation of a left ventricular assist device and dissociated enzymatically. A clear population of CD19 + cells is shown. Representative plot from 3 heart samples analyzed. % of myocardial CD45+ cells is reported next to the gate. G) Histological analysis of human myocardium collected at the time of LVAD placement shows that, similarly to the murine heart, the human heart harbors B cells in the intravascular space, in intimate contact with the endothelium. 40X magnification. RBC = Red blood cells. Pair wise comparisons were performed with two-way t test. All graph bars represent average ± standard deviation. The WT and uMT groups were compared using unpaired 2 way t test adjusted for multiple comparisons with the False Discovery Rate Method in panels A and B. In panel C the two groups were compared using nested t test *= p<0.05. **= p<0.01. Table 1 -Pathway analysis of genes differentially expressed between myocardial and circulating B cells. ) KEGG pathway analysis of genes differentially expressed in myocardial B cells in comparison to circulating B cells. Top 10 differentially expressed KEGG pathways in the "environmental information processing", "organismal systems" and "metabolism" KEGG pathway categories. P =p value adjusted for multiple comparison with the Benjamini-Hochberg procedure.
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